Necrotizing enterocolitis in premature infants at different gestation ages.


Journal

Wiadomosci lekarskie (Warsaw, Poland : 1960)
ISSN: 0043-5147
Titre abrégé: Wiad Lek
Pays: Poland
ID NLM: 9705467

Informations de publication

Date de publication:
2024
Historique:
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 1 5 2024
Statut: ppublish

Résumé

Aim: To compare X-ray signs in different gestational and body weight groups of patients with NEC. Materials and Methods: We conducted a retrospective study, enrolling 52 preterm newborns with symptoms of NEC regardless of onset time, who underwent treatment at Neonatal Intensive Care Units in Municipal Non-commercial enterprise "City Children Hospital №2", Odesa. The patients were split into 3 clinical groups: very preterm newborns (VPN), moderately preterm newborns (MPN), and moderately preterm newborns with intrauterine growth restriction (MPN+IUGR). Results: In the VPN group NEC was diagnosed at stage II (58,82±12,30) % and III (41,18±12,30) % by Bell MJ, р>0,05. In the group MPN+IUGR, NEC stage II (33,33±14,21) % and stage III (66,66 ±14,21) %, р>0,05, were equally observed. In the MPN group, NEC was diagnosed at stage I (41,67±10,28) % and II (58,33±10,28) %, р>0,05, without prevalence of any. Also only localized forms were observed. In VPN, we observed localized forms in most cases, while diffuse forms were diagnosed in (11,76±8,05) % cases, р<0,05. In the MPN+IUGR group, we found diffuse form of the NEC in half of the cases - (50,00±15,08) %. In the VPN and MPN+IUGR groups, NEC developed at 13,23±0,39 and 14,33±1,19 days, respectively. However, in MPN without IUGR, NEC developed at 17,75±0,55 days, significantly later than in the MPN+IUGR group, р<0,05. Conclusions: We have described distinct features of NEC in MPN with IUGR. Compared to MPN without IUGR, NEC had more severe course and earlier manifestation in such neonates.

Identifiants

pubmed: 38691780
doi: 10.36740/WLek202403106
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-416

Auteurs

Kateryna Doikova (K)

BARUCH PADEH MEDICAL CENTER, PORIA, ISRAEL.

Michael Jerdev (M)

BARUCH PADEH MEDICAL CENTER, PORIA, ISRAEL.

Larysa Koval (L)

ODESA NATIONAL MEDICAL UNIVERSITY, ODESA, UKRAINE.

Dmytro Valantsevych (D)

COMMUNAL NONPROFIT ENTERPRISE "CITY CLINICAL HOSPITAL №11" ODESA CITY COUNCIL, ODESA, UKRAINE.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH